Ex-Adaptive CFO Schorno Resurfaces Quickly At 23andMe

Dean Schorno has joined 23andMe, a genetic information company with drug development aspirations, as its chief financial officer and head of operations. Schorno was previously at Seattle’s Adaptive Biotechnologies for a year and before that at Bay Area diagnostics company Genomic Health. Adaptive said last week that Chad Cohen would replace Schorno as CFO.

Alex Lash is Xconomy's National Biotech Editor. He is based in San Francisco. Follow @alexlash

Trending on Xconomy